Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Monday, May 5, 2014. Pfizer Inc. (NYSE:PFE) shares after opening at $31.77 moved to $31.99 on last trade day and at the end of the day closed at $31.82. Company price to sales ratio in past twelve months was calculated as 4.20 and price to cash ratio as 6.69. Pfizer Inc. (NYSE:PFE) showed a negative weekly performance of -0.34%.
Writing a letter to Gilead Sciences, Inc. (NASDAQ:GILD)’s Chief Executive John C. Martin, two Democratic lawmakers have asked to explain the reason, behind the exorbitant pricing of the drug.
Gilead Sciences, Inc. (NASDAQ:GILD) shares advanced 1.25% in last trading session and ended the day on $73.03. GILD return on equity ratio is recorded as 28.30% and its return on assets is 13.70%. Gilead Sciences, Inc. (NASDAQ:GILD) yearly performance is 62.36%.
Ariad Pharmaceuticals, Inc. logo Investment analysts at HC Wainwright initiated coverage on shares of Ariad Pharmaceuticals (NASDAQ:ARIA) in a note issued to investors on Tuesday, Stock Ratings Network reports. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares moved up 2.11% in last trading session and was closed at $7.76, while trading in range of $7.58 – $7.98. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) year to date (YTD) performance is 13.78%.
Shares of MannKind (NASDAQ:MNKD) were the recipient of some unusual options trading activity on Monday. Traders purchased 21,101 call options on the company, AnalystRatings.NET reports. This is an increase of approximately 105% compared to the average daily volume of 10,311 call options.
MannKind Corporation (NASDAQ:MNKD) weekly performance is 2.65%. On last trading day company shares ended up $5.80. MannKind Corporation (NASDAQ:MNKD) distance from 50-day simple moving average (SMA50) is 1.10%. Analysts mean target price for the company is $7.21.
Leave a Reply